DEFR14A: Franklin Covey Amends Proxy Statement to Include Equity Compensation Plan Details

Sentiment:

Proxy Statement Amendment


Franklin Covey has amended its proxy statement to include historical information regarding securities authorized for issuance under its equity compensation plans as of August 31, 2024.

Summary

  • Franklin Covey Co. has filed an amendment to its definitive proxy statement related to the upcoming 2025 Annual Meeting of Shareholders.
  • The amendment includes details about securities authorized for issuance under the company's equity compensation plans as of August 31, 2024.
  • As of August 31, 2024, there were 905,000 shares to be issued upon exercise of outstanding options, warrants, and rights under equity compensation plans approved by security holders.
  • The weighted-average exercise price of outstanding options, warrants, and rights was not specified.
  • There were 996,000 securities remaining available for future issuance under equity compensation plans.
  • The company had approximately 689,000 shares authorized for purchase by participants in its Employee Stock Purchase Plan at August 31, 2024.
  • The original proxy statement was filed on December 20, 2024, and amended on January 13, 2025.
  • The Annual Meeting of Shareholders will be held on January 24, 2025.
  • Shareholders who have already voted do not need to vote again unless they wish to change or revoke their prior vote.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing, so the sentiment is neutral.

Future Outlook

The number of performance-based plan shares expected to be awarded at August 31, 2024 may change in future periods based upon the achievement of specified goals and revisions to estimates.

Industry Context

This announcement is a standard regulatory filing related to shareholder meetings and equity compensation, common among publicly traded companies.

Comparison to Industry Standards

  • Many publicly traded companies use omnibus incentive plans to attract and retain employees.
  • The specific number of shares authorized and the terms of the plans vary widely based on company size, industry, and performance.
  • Companies like Oracle, Microsoft, and Apple also disclose similar information in their proxy statements.

Stakeholder Impact

  • Shareholders are provided with additional information regarding the company's equity compensation plans.
  • This information can influence shareholder voting decisions at the Annual Meeting.

Key Dates

DateDescription
December 20, 2024Original definitive proxy statement filed
January 13, 2025Amendment No. 1 to the proxy statement filed
January 24, 2025Annual Meeting of Shareholders
August 31, 2024Date for securities authorized for issuance under equity compensation plans

Keywords

proxy statement, equity compensation, annual meeting, shareholders, securities, Franklin Covey

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.